0 items USD 0.00Search
Your search for "icd research acorda therapeutics inc pharmaceuticals healthcare company profile swot" gave back 1521200 results.
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Relapsing-Remitting Multiple Sclerosis market will...
Catalog:
Arsta
March 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Spinal Cord Injury Therapeutic market will undergo major...
Catalog:
Arsta
January 2022
Price: USD 3,360.00
The “Musculoskeletal Medicine Industry Forecast” looks at past sales and reviews total world Musculoskeletal Medicine sales in 2022, providing a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Syndromes Progressive Ataxia Weakness Disorders market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Market Analysis and Insights: Global Musculoskeletal Medicine Market The global Musculoskeletal Medicine market is projected to grow from US$ million...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Primary Sclerosing Cholangitis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
January 2018
Price: USD 2,000.00
Primary Sclerosing Cholangitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
July 2018
Price: USD 2,000.00
The global Syndromes Progressive Ataxia Weakness Disorders market size was valued at USD million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Migraine - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine -...
Catalog:
Global Markets Direct
November 2020
Price: USD 2,000.00
Migraine - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine –...
Catalog:
Global Markets Direct
May 2020
Price: USD 2,000.00
Primary Sclerosing Cholangitis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
February 2019
Price: USD 2,000.00
Migraine - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine -...
Catalog:
Global Markets Direct
October 2018
Price: USD 2,000.00
Migraine - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine -...
Catalog:
Global Markets Direct
April 2018
Price: USD 2,000.00
Dementia - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia -...
Catalog:
Global Markets Direct
March 2019
Price: USD 2,000.00
5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H2 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
